Sculptor Capital’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,250
Closed -$15.1K 380
2024
Q3
$15.1K Buy
+1,250
New +$34.1K ﹤0.01% 297
2023
Q3
Sell
-8,333
Closed -$2.58M 466
2023
Q2
$2.58M Buy
+8,333
New +$2.55M 0.05% 138
2023
Q1
Sell
-49,049
Closed -$14.6M 663
2022
Q4
$14.6M Hold
49,049
0.25% 71
2022
Q3
$14.3M Hold
49,049
0.18% 119
2022
Q2
$14.2M Hold
49,049
0.15% 136
2022
Q1
$14.3M Hold
49,049
0.11% 160
2021
Q4
$14.2M Buy
49,049
+24,524
+100% +$7.15M 0.12% 131
2021
Q3
$7.12M Buy
+24,525
New +$7.12M 0.06% 232

Other funds holding XAGE

Sculptor Capital's XAGE Position: Q4 2024 in Review

Sculptor Capital sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q4 2024, closing a stake of 1,250 shares — an estimated $15.1K sold.

Sculptor Capital first reported a position in XAGE in Q3 2021 and held it in 8 quarters. The position peaked at $14.6M in Q4 2022. 21 funds tracked by Wall St. Rank hold XAGE as of Q4 2024.

  • Sculptor Capital reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Sculptor Capital sold 1,250 Longevity Health Holdings, Inc. Common Stock shares in Q4 2024, an estimated $15.1K.
  • Sculptor Capital first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
  • Sculptor Capital's Longevity Health Holdings, Inc. Common Stock position peaked at $14.6M in Q4 2022.
  • 21 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q4 2024.

Based on Sculptor Capital's 13F filing for Q4 2024, filed 14 Feb 2025.